Hemostemix Inc. Share Price
Stocks
HEM
CA4236943060
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0600 CAD | -.--% |
|
-.--% | -33.33% |
| 07-31 | Hemostemix Raises C$322,250 From Second Tranche of Private Placement | MT |
| 07-08 | Hemostemix Files Commercialization Application for Treatment of Vascular Dementia, Refractory Angina and Pain | MT |
| Market Cap | 11.87M 8.44M 7.33M 6.83M 6.28M 803M 12M 80.54M 31.49M 401M 31.69M 30.99M 1.33B | P/E 2024 |
-4.36x | P/E 2025 | -3.12x |
|---|---|---|---|---|---|
| Enterprise Value | 14.73M 10.47M 9.09M 8.48M 7.79M 996M 14.89M 99.96M 39.07M 498M 39.33M 38.47M 1.65B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
82.86% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 month | +9.09% | ||
| 6 months | -36.84% | ||
| Current year | -33.33% |
| 1 week | 0.06 |  | 0.07 |
| 1 month | 0.04 | | 0.07 |
| Current year | 0.04 | | 0.11 |
| 1 year | 0.04 | | 0.14 |
| 3 years | 0.04 | | 0.42 |
| 5 years | 0.04 | | 0.42 |
| 10 years | 0 | | 5.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Smeenk
CEO | Chief Executive Officer | - | 09/02/2020 |
Christina Wu
DFI | Director of Finance/CFO | - | 04/03/2020 |
Fraser Henderson
CTO | Chief Tech/Sci/R&D Officer | - | 13/10/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Smeenk
BRD | Director/Board Member | - | 25/11/2019 |
Ronnie Hershmann
BRD | Director/Board Member | 67 | 08/02/2020 |
Loran Swanberg
BRD | Director/Board Member | - | 07/04/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 22/07/26 | Option | Director | 385,000 | 0.1946% | ||
| 22/07/26 | Option | Founder | 1,730,000 | 0.8746% | ||
| 18/12/25 | Option | Director | 65,000 | 0.0345% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -40.00% | -47.83% | 8.45M | |
| +10.00% | +13.39% | +51.99% | +83.45% | 56.7B | |
| +0.80% | -5.70% | +23.89% | +62.65% | 51.97B | |
| -1.05% | -0.92% | -16.75% | -13.98% | 23.33B | |
| +0.27% | -5.25% | -11.31% | +348.66% | 21.34B | |
| +1.73% | -1.57% | +32.81% | -25.80% | 17.44B | |
| +4.29% | +1.67% | +201.24% | +344.48% | 14.77B | |
| +2.16% | -0.74% | +52.38% | +176.71% | 13.84B | |
| +3.08% | +3.36% | +438.48% | +180.13% | 12.12B | |
| +5.36% | -5.57% | +63.02% | +161.63% | 11.14B | |
| Average | +2.58% | -0.56% | +79.58% | +127.01% | 22.26B | |
| Weighted average by Cap. | +3.58% | +0.44% | +62.17% | +117.53% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.62M -1.86M -1.62M -1.51M -1.38M -177M -2.65M -17.75M -6.94M -88.45M -6.99M -6.83M -293M | -4.71M -3.35M -2.91M -2.71M -2.49M -319M -4.77M -31.99M -12.5M -159M -12.59M -12.31M -528M |
| Net Debt | 4.23M 3.01M 2.61M 2.44M 2.24M 286M 4.28M 28.71M 11.22M 143M 11.3M 11.05M 474M | 2.86M 2.03M 1.77M 1.65M 1.51M 193M 2.89M 19.41M 7.59M 96.71M 7.64M 7.47M 320M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | CA$0.0600 | -.--% | 24,384 |
| 30/07/26 | CA$0.0600 | -.--% | 3,422 |
| 29/07/26 | CA$0.0600 | -14.29% | 32,635 |
| 28/07/26 | CA$0.0700 | +16.67% | 179,822 |
- Stock Market
- Stocks
- HEM Stock
Select your edition
All financial news and data tailored to specific country editions
